[Labile diabetes. Pathophysiology, clinical aspects, therapy].
D001645:Biguanides / Q000627:therapeutic use*; D050260:Carbohydrate Metabolism; D003550:Cystic Fibrosis / Q000150:complications*; D003920:Diabetes Mellitus / Q000503:physiopathology*; D003929:Diabetic Neuropathies / Q000209:etiology*; D005705:Gallbladder Diseases; D005767:Gastrointestinal Diseases; D006801:Humans; D007328:Insulin; D010182:Pancreatic Diseases / Q000503:physiopathology*
D001645:Biguanides; D007328:Insulin
Der labile Diabetes. Pathophysiologie, Klinik, Therapie.